アブレーション技術市場規模、シェア、動向、2031年までの世界予測

アブレーション技術市場は、2026年の161億8000万米ドルから2031年には275億6000万米ドルに成長し、予測期間中の年平均成長率は11.2%に達するとMarketsandMarketsでは予測しています。

心血管疾患、がん、慢性疼痛、婦人科疾患などの慢性疾患の増加に伴い、アブレーション技術に対する需要が非常に高まっています。慢性疾患の増加は、低侵襲手術の普及率を高めると予想されます。従来の外科手術よりも低侵襲手術が好まれる傾向は、市場における重要な要素です。これは、入院期間の短縮、回復の迅速化、痛みの軽減、合併症リスクの低減、瘢痕の軽減など、アブレーションに伴う多くの利点によるものです。さらに、世界的に高齢者人口が増加していることも、患者数の増加につながっています。高周波アブレーション、マイクロ波アブレーション、凍結アブレーション、レーザーアブレーション、パルスフィールドアブレーションなどの技術革新により、手術の安全性と精度が向上しています。

調査概要：

本レポートは、アブレーション技術市場を分析し、技術、製品、用途、エンドユーザー、地域といった様々なセグメントに基づき、市場規模と将来の成長可能性を推定することを目的としています。また、主要企業の競合分析に加え、企業プロファイル、サービス内容、最近の動向、主要な市場戦略についても詳述しています。

本レポートをご購入する理由

本レポートは、アブレーション技術市場全体の収益に関する最も正確な推定値を提供することで、市場リーダーや新規参入企業を支援します。関係者は、本レポートを通じて競争環境を理解し、より的確な事業展開と適切な市場参入戦略の策定に必要な知見を得ることができます。さらに、市場の動向を把握し、主要な市場推進要因、阻害要因、課題、機会に関する情報を提供することで、関係者の意思決定を支援します。

本レポートは、以下のポイントに関する洞察を提供します。

主要な推進要因（新興アブレーション技術、慢性疾患の罹患率の上昇、世界的な高齢者人口の増加）、阻害要因（代替療法の強力な市場地位、高度なアブレーション機器および処置の高コスト、厳格な規制システム）、機会（新興経済国における成長可能性）、および課題（特定のアブレーション処置における長期的な有効性と再発率に関する懸念、市場参加者間の激しい競争による価格圧力と急速な技術陳腐化）の分析。

• 市場浸透：アブレーション技術市場における主要企業が提供する製品に関する詳細な情報が含まれています。本レポートは、製品、用途、エンドユーザー、地域といった様々なセグメントを網羅しています。
• 製品強化／イノベーション：世界のアブレーション技術市場における新製品の発売と予測されるトレンドに関する包括的な詳細情報。
• 市場開発：技術、製品、用途、エンドユーザー、地域別に、収益性の高い成長市場に関する徹底的な知識と分析。
• 市場の多様化：アブレーション技術市場における新製品、拡大市場、最新の技術進歩、および投資に関する包括的な情報。
• 競合評価：アブレーション技術市場における主要競合企業の市場シェア、成長戦略、製品ラインナップ、および生産能力を徹底的に評価。

Report Description

The ablation technology market is projected to reach USD 27.56 billion by 2031 from USD 16.18 billion in 2026, at a CAGR of 11.2% during the forecast period.

There has been a huge demand for ablation technology due to an increasing number of chronic diseases, such as cardiovascular diseases, cancer, chronic pain, and gynecological diseases. The growing incidence of chronic diseases is expected to fuel the adoption rate of minimally invasive procedures. The preference for minimally invasive surgery over the traditional surgical method is a significant factor in the market. It can be credited to the benefits associated with ablation, including shorter hospital stay, quick recovery, low pain, low risks of developing complications, and reduced scarring. In addition to that, the increasing population of the geriatric segment across the globe is increasing the patient pool. Innovation in radiofrequency ablation, microwave ablation, cryoablation, laser ablation, and pulsed field ablation is ensuring procedural safety and accuracy.

“By product, the consumables segment is expected to lead the ablation technology market.”

The consumables category has the largest market share in the product category of ablation technologies, owing to the increasing use of these products in performing ablation procedures for different medical applications, such as cardiology, oncology, pain management, and gynecology. Products such as catheters, electrodes, probes, needles, and disposables are essential components consistently utilized in ablation procedures, resulting in a steady demand for these items from hospitals, surgery centers, and ablation clinics. The rising number of minimally invasive ablation procedures has created a huge demand for these disposables.

“By end user, the hospitals, surgical centers, and ablation centers segment is estimated to account for the largest share of the ablation technology market.”

By end user, hospitals, surgery centers, and ablation centers account for the largest share of the ablation technology market due to the high volume of ablation treatments performed in these institutions, as well as the availability of advanced healthcare facilities. Such healthcare institutions are equipped with special operation theaters, modern imaging and navigation technologies, and highly qualified healthcare personnel to perform complicated ablations in connection with cardiovascular diseases, cancer, chronic pain, and gynecological conditions. Hospitals and specialized ablation centers are most popular among patients due to the provision of complete healthcare services and facilities.

“The US is expected to register the highest CAGR in the North America ablation technology market.”

The US is anticipated to register the highest CAGR in the ablation technology market in North America because of the increasing prevalence of many kinds of chronic diseases, such as heart disease, cancer, chronic pain, and atrial fibrillation, thus making it essential to conduct minimally invasive surgeries. The US has a highly developed healthcare system, a high rate of adoption of the latest technologies, and the presence of leading medical device companies that constantly invest in R&D in the field of ablation devices. Rising preference for minimally invasive surgeries, aging population, and rising awareness are driving the market.

A breakdown of the primary participants (supply-side) for the ablation technology market referred to in this report is provided below:

• By Company Type: Tier 1–35%, Tier 2–40%, and Tier 3–25%
• By Designation: C-level–45%, Director Level–35%, and Others–20%
• By Region: North America–27%, Europe–25%, Asia Pacific–30%, Latin America- 8%, Middle East & Africa-10%.

Prominent players in the ablation technology market are Johnson & Johnson (US), Medtronic (Ireland), Boston Scientific Corporation (US), Abbott Laboratories (US), ArtiCure, Inc. (US), and AngioDynamics (US).

Research Coverage:

The report analyzes the ablation technology market and aims at estimating the market size and future growth potential of this market based on various segments such as technology, product, application, end user, and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall ablation technology market. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

Analysis of key drivers (Emerging ablation technologies, Rising prevalence of chronic diseases, Increasing geriatric population worldwide), restraints (Strong market positioning of alternative therapies, High cost of advanced ablation devices and procedures, Stringent regulatory systems), opportunities (Growth potential in emerging economies) and challenges (Concerns regarding long-term efficacy and recurrence rates in certain ablation procedures, Intense competition among market players leading to pricing pressure and rapid technological obsolescence).

• Market Penetration: It includes extensive information on products offered by the major players in the ablation technology market. The report includes various segments in product, application, end user, and region.
• Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global ablation technology market.
• Market Development: Thorough knowledge and analysis of the profitable rising markets by technology, product, application, end user and region.
• Market Diversification: Comprehensive information about newly launched products, expanding markets, current advancements, and investments in the ablation technology market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products, and capacities of the major competitors in the ablation technology market.

Table of Contents

1 INTRODUCTION 33
1.1 STUDY OBJECTIVES 33
1.2 MARKET DEFINITION 33
1.3 STUDY SCOPE 34
1.3.1 MARKET SEGMENTATION AND REGIONS CONSIDERED 34
1.3.2 INCLUSIONS & EXCLUSIONS 35
1.3.3 YEARS CONSIDERED 35
1.3.4 CURRENCY CONSIDERED 36
1.3.5 UNITS CONSIDERED 36
1.4 STAKEHOLDERS 36
1.5 SUMMARY OF CHANGES 36
2 EXECUTIVE SUMMARY 38
2.1 KEY INSIGHTS & MARKET HIGHLIGHTS 38
2.2 KEY MARKET PARTICIPANTS: INSIGHTS & DEVELOPMENTS 41
2.3 DISRUPTIVE TRENDS SHAPING MARKET GROWTH 42
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 43
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 44
3 PREMIUM INSIGHTS 45
3.1 ABLATION TECHNOLOGY MARKET OVERVIEW 45
3.2 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY PRODUCT AND COUNTRY (2025) 46
3.3 ABLATION TECHNOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES (2025) 47
3.4 ABLATION TECHNOLOGY MARKET, BY REGION (2024−2031) 48
3.5 ABLATION TECHNOLOGY MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES 48
4 MARKET OVERVIEW 49
4.1 INTRODUCTION 49
4.1.1 DRIVERS 50
4.1.1.1 Emerging ablation technologies 50
4.1.1.2 Increasing demand for minimally invasive procedures 50
4.1.1.3 Increasing geriatric population worldwide 51
4.1.1.4 Rising prevalence of chronic diseases 51
4.1.2 RESTRAINTS 53
4.1.2.1 Strong market positioning of alternative therapies 53
4.1.2.2 Stringent regulatory systems 54
4.1.2.3 High cost of advanced ablation devices and procedures 54
4.1.3 OPPORTUNITIES 55
4.1.3.1 Growth potential in emerging economies 55
4.1.3.2 Growing demand for pulsed field ablation (PFA) and non-thermal ablation technologies 56
4.1.4 CHALLENGES 57
4.1.4.1 Concerns regarding long-term efficacy and recurrence rates in certain ablation procedures 57
4.1.4.2 Therapeutic challenges and hazardous effects of ablation 57
4.2 UNMET NEEDS AND WHITE SPACES 58
4.2.1 UNMET NEEDS IN ABLATION TECHNOLOGY MARKET 58
4.2.2 WHITE SPACE OPPORTUNITIES 59
4.3 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 60
4.3.1 INTERCONNECTED MARKET 60
4.3.2 CROSS-SECTOR OPPORTUNITIES 61
4.4 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 63
5 INDUSTRY TRENDS 64
5.1 PORTER’S FIVE FORCES ANALYSIS 64
5.1.1 THREAT OF NEW ENTRANTS 65
5.1.2 THREAT OF SUBSTITUTES 65
5.1.3 BARGAINING POWER OF SUPPLIERS 65
5.1.4 BARGAINING POWER OF BUYERS 65
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 65
5.2 MACROECONOMIC OUTLOOK 66
5.2.1 INTRODUCTION 66
5.2.2 GDP TRENDS AND FORECAST 66
5.2.3 TRENDS IN GLOBAL ELECTROPHYSIOLOGY INDUSTRY 68
5.2.4 TRENDS IN GLOBAL PAIN MANAGEMENT DEVICES INDUSTRY 68
5.3 SUPPLY CHAIN ANALYSIS 68
5.4 VALUE CHAIN ANALYSIS 69
5.4.1 RESEARCH & PRODUCT DEVELOPMENT 70
5.4.2 RAW MATERIAL PROCUREMENT AND MANUFACTURING 70
5.4.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES 71
5.5 ECOSYSTEM ANALYSIS 71
5.6 PRICING ANALYSIS (2023–2025) 72
5.6.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER (2025) 72
5.6.2 AVERAGE SELLING PRICE TREND, BY REGION (2023–2025) 72
5.7 TRADE ANALYSIS 73
5.7.1 IMPORT SCENARIO FOR HS CODE 9018 73
5.7.2 EXPORT SCENARIO FOR HS CODE 9018 74
5.8 KEY CONFERENCES AND EVENTS, 2026–2027 74
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 75
5.10 INVESTMENT & FUNDING SCENARIO 76
5.11 CASE STUDY ANALYSIS 76
5.11.1 CASE STUDY 1: RADIOFREQUENCY ABLATION ANALYSIS CASE STUDY 76
5.11.2 CASE STUDY 2: THERMOCOOL CATHETER CASE STUDY 77
5.11.3 CASE STUDY 3: HYBRID ABLATION LEFT VENTRICULAR FUNCTION NORMALIZED, MEDICATION REDUCED 77
5.12 IMPACT OF US TARIFFS—ABLATION TECHNOLOGY MARKET 78
5.12.1 INTRODUCTION 78
5.12.2 KEY TARIFF RATES 79
5.12.3 PRICE IMPACT ANALYSIS 80
5.12.4 IMPACT ON COUNTRIES/REGIONS 80
5.12.4.1 US 80
5.12.4.2 Europe 81
5.12.4.3 Asia Pacific 81
5.12.5 IMPACT ON END-USER INDUSTRIES 81
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 83
6.1 KEY EMERGING TECHNOLOGIES 83
6.1.1 THERMAL ABLATION TECHNOLOGY 83
6.1.2 NON-THERMAL ABLATION TECHNOLOGY 83
6.2 COMPLEMENTARY TECHNOLOGIES 84
6.2.1 MEDICAL COOLING SYSTEMS 84
6.3 ADJACENT TECHNOLOGIES 84
6.3.1 ABLATION PLANNING SOFTWARE 84
6.4 TECHNOLOGY/PRODUCT ROADMAP 84
6.4.1 SHORT-TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION 85
6.4.2 MID-TERM (2027–2030) | EXPANSION & STANDARDIZATION 86
6.4.3 LONG-TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION 87
6.5 PATENT ANALYSIS 88
6.6 FUTURE APPLICATIONS OF ABLATION TECHNOLOGY 89
6.7 IMPACT OF AI/GEN AI ON ABLATION TECHNOLOGY MARKET 90
6.7.1 TOP USE CASES AND MARKET POTENTIAL 91
6.7.2 BEST PRACTICES IN ABLATION TECHNOLOGY PROCESSING 92
6.7.3 CASE STUDIES OF AI IMPLEMENTATION IN ABLATION TECHNOLOGY 93
6.7.4 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS 94
6.7.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN
ABLATION TECHNOLOGY MARKET 95
7 REGULATORY LANDSCAPE 97
7.1 REGIONAL REGULATIONS AND COMPLIANCE 97
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97
7.1.2 REGULATORY FRAMEWORK 97
7.1.2.1 North America 97
7.1.2.1.1 US 97
7.1.2.1.2 Canada 99
7.1.2.2 Europe 101
7.1.2.3 Asia Pacific 103
7.1.2.3.1 Japan 103
7.1.2.3.2 China 104
7.1.2.3.3 India 106
7.1.2.4 Latin America 106
7.1.2.4.1 Brazil 106
7.1.3 INDUSTRY STANDARDS 106
7.2 CERTIFICATIONS, LABELING, AND ECO-STANDARDS 107
8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 109
8.1 DECISION-MAKING PROCESS 109
8.2 KEY STAKEHOLDERS AND EVALUATION CRITERIA 109
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 109
8.2.2 BUYING CRITERIA 110
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 111
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 112
8.5 MARKET PROFITABILITY 112
8.5.1 REVENUE POTENTIAL 112
8.5.2 COST DYNAMICS 113
8.5.3 MARGIN OPPORTUNITIES IN KEY APPLICATIONS 113
9 ABLATION TECHNOLOGY MARKET, BY TYPE 114
9.1 INTRODUCTION 115
9.2 RADIOFREQUENCY ABLATION 115
9.2.1 LOWER COST AND HIGHER EFFICACY TO PROPEL MARKET GROWTH 115
9.3 LASER/LIGHT ABLATION 117
9.3.1 LOWER RISK OF TISSUE DAMAGE AND BETTER REAL-TIME
MONITORING TO AID MARKET GROWTH 117
9.4 ULTRASOUND ABLATION 118
9.4.1 HIGH INCIDENCE OF LIVER TUMORS AND CANCER TO FUEL MARKET GROWTH 118
9.5 CRYOABLATION 119
9.5.1 FEWER COMPLICATIONS AND SHORTER PROCEDURAL TIME TO DRIVE MARKET 119
9.6 MICROWAVE ABLATION 120
9.6.1 FASTER ABLATION TIME AND LESSER PROCEDURAL PAIN TO AUGMENT MARKET GROWTH 120
9.7 PULSED FIELD ABLATION 121
9.7.1 IMPROVED SAFETY, SHORTER PROCEDURAL TIME, AND FEWER COMPLICATIONS TO PROPEL MARKET GROWTH 121
9.8 HYDROTHERMAL/HYDROMECHANICAL ABLATION 122
9.8.1 INCREASED USAGE IN GYNECOLOGICAL DISORDERS AND MENORRHAGIA TO AID MARKET GROWTH 122
9.9 OTHER ABLATION TECHNOLOGIES 123
10 ABLATION TECHNOLOGY MARKET, BY PRODUCT 125
10.1 INTRODUCTION 126
10.2 SYSTEMS 126
10.2.1 RADIOFREQUENCY ABLATION SYSTEMS 127
10.2.1.1 Temperature-controlled RF ablation systems 128
10.2.1.1.1 Technological advancements and improved clinical outcomes to propel segment growth 128
10.2.1.2 Irrigated RF ablation systems 129
10.2.1.2.1 Enhanced lesion formation and improved procedural efficiency to support market growth 129
10.2.1.3 Multi-electrode RF ablation systems 130
10.2.1.3.1 Reduced procedure time and improved ablation precision to accelerate segment adoption 130
10.2.1.4 Bipolar RF systems 131
10.2.1.4.1 Superior energy delivery control and precise tissue targeting to drive market growth 131
10.2.2 LASER/LIGHT ABLATION SYSTEMS 132
10.2.2.1 Excimer laser ablation systems 133
10.2.2.1.1 Low direct tissue interaction, precise ablation zone, and high procedural efficiency to drive adoption 133
10.2.2.2 CO2 laser ablation systems 134
10.2.2.2.1 High precision tissue vaporization and minimal bleeding to support market growth 134
10.2.2.3 Diode laser ablation systems 135
10.2.2.3.1 Compact design, energy efficiency, and versatile clinical applications to accelerate segment growth 135
10.2.2.4 Other laser/light ablation systems 136
10.2.3 ULTRASOUND ABLATION SYSTEMS 137
10.2.3.1 High-intensity focused ultrasound ablation systems 138
10.2.3.1.1 Low procedural time and reduced bleeding to support system adoption 138
10.2.3.2 Magnetic resonance-guided focused ultrasound ablation systems 139
10.2.3.2.1 Non-pregnancy safe treatment procedure to limit adoption 139
10.2.4 CRYOABLATION SYSTEMS 140
10.2.4.1 Technological advancements and introduction of new cryoprobes to aid adoption 140
10.2.5 PULSED FIELD ABLATION SYSTEMS 141
10.2.5.1 Tissue-selective ablation and reduced thermal injury to accelerate market adoption 141

10.2.6 MICROWAVE ABLATION SYSTEMS 143
10.2.6.1 Production of large ablation zones without a heat-sink effect on surrounding tissues to drive market 143
10.2.7 HYDROTHERMAL/HYDROMECHANICAL ABLATION SYSTEMS 144
10.2.7.1 Increased need for minimally invasive procedures for gynecological disorders to support market growth 144
10.2.8 OTHER ABLATION SYSTEMS 145
10.3 CONSUMABLES 147
10.3.1 GROWING PREFERENCE FOR ADVANCED MINIMALLY INVASIVE PROCEDURES TO SPUR MARKET GROWTH 147
11 ABLATION TECHNOLOGY MARKET, BY APPLICATION 148
11.1 INTRODUCTION 149
11.2 CVD TREATMENT 149
11.2.1 INCREASING TARGET PATIENT POPULATION TO PROPEL MARKET GROWTH 149
11.3 CANCER TREATMENT 150
11.3.1 HIGH PREVALENCE OF CANCER AND NEED FOR ADVANCED TREATMENT PROCEDURES TO AUGMENT MARKET GROWTH 150
11.3.2 LIVER CANCER 151
11.3.3 KIDNEY CANCER 151
11.3.4 PROSTATE CANCER 151
11.3.5 LUNG CANCER 151
11.3.6 BONE METASTASIS 152
11.3.7 BREAST CANCER 152
11.4 ORTHOPEDIC TREATMENT 153
11.4.1 GROWING DISEASE PREVALENCE AND RISING GERIATRIC POPULATION TO SPUR MARKET GROWTH 153
11.5 COSMETIC/AESTHETIC SURGERY 154
11.5.1 INCREASING DEMAND FOR AESTHETIC SURGICAL PROCEDURES TO FUEL MARKET GROWTH 154
11.6 UROLOGICAL TREATMENT 155
11.6.1 HIGH DEMAND FOR MINIMALLY INVASIVE PROCEDURES AMONG PATIENTS TO DRIVE MARKET 155
11.7 GYNECOLOGICAL TREATMENT 155
11.7.1 INCREASING REPRODUCTIVE HEALTH CONCERNS AND DECREASING FERTILITY RATE TO PROPEL MARKET GROWTH 155
11.8 PAIN MANAGEMENT 156
11.8.1 MINIMUM RECOVERY TIME AND LONG-LASTING PAIN RELIEF TO SUPPORT MARKET GROWTH 156
11.9 OPHTHALMOLOGICAL TREATMENT 157
11.9.1 RISING PREVALENCE OF VISION DISORDERS AMONG ALL AGE GROUPS TO AID MARKET GROWTH 157
11.10 OTHER APPLICATIONS 158

12 ABLATION TECHNOLOGY MARKET, BY END USER 159
12.1 INTRODUCTION 160
12.2 HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS 160
12.2.1 HIGH ADOPTION OF ROBOTIC PROCEDURES IN SURGERIES
AND IMPROVED HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET 160
12.3 AMBULATORY SURGERY CENTERS 161
12.3.1 NEED FOR COST-EFFECTIVE OUTPATIENT TREATMENTS
TO SPUR MARKET GROWTH 161
12.4 MEDICAL SPAS AND AESTHETIC & DERMATOLOGY CLINICS 162
12.4.1 INCREASING PREFERENCE FOR MINIMALLY INVASIVE AND
NON-INVASIVE AESTHETIC PROCEDURES TO BOOST MARKET GROWTH 162
12.5 OTHER END USERS 163
13 ABLATION TECHNOLOGY MARKET, BY REGION 164
13.1 INTRODUCTION 165
13.2 NORTH AMERICA 165
13.2.1 US 171
13.2.1.1 US to dominate North American market during forecast period 171
13.2.2 CANADA 175
13.2.2.1 Rising burden of cancer and growing demand for minimally invasive procedures to support market growth 175
13.3 EUROPE 180
13.3.1 GERMANY 185
13.3.1.1 Developed healthcare infrastructure and high incidence of chronic diseases to support market growth 185
13.3.2 FRANCE 189
13.3.2.1 Growing geriatric population and rising prevalence of cancer to aid market growth 189
13.3.3 UK 194
13.3.3.1 Rising target patient population and growing awareness about advanced treatment options to drive market 194
13.3.4 ITALY 198
13.3.4.1 Increasing number of clinical trials and growing focus on advanced research activities to augment market growth 198
13.3.5 SPAIN 203
13.3.5.1 Increasing government research funding and growing focus on effective cancer diagnosis to propel market growth 203
13.3.6 REST OF EUROPE 207
13.4 ASIA PACIFIC 211
13.4.1 JAPAN 217
13.4.1.1 Presence of a universal healthcare reimbursement system to augment market growth 217
13.4.2 CHINA 221
13.4.2.1 Increased patient pool and favorable government initiatives to fuel market growth 221
13.4.3 INDIA 226
13.4.3.1 Modernization of healthcare infrastructure and increased medical tourism to aid market growth 226
13.4.4 AUSTRALIA 230
13.4.4.1 Increased research investments and favorable government initiatives to spur market growth 230
13.4.5 SOUTH KOREA 235
13.4.5.1 Focus on healthcare R&D and supportive government initiatives to positively impact market growth 235
13.4.6 REST OF ASIA PACIFIC 239
13.5 LATIN AMERICA 243
13.5.1 BRAZIL 247
13.5.1.1 Increasing government funding and growing burden of chronic diseases to propel market growth 247
13.5.2 MEXICO 252
13.5.2.1 Availability of advanced care initiatives and awareness programs to fuel market growth 252
13.5.3 REST OF LATIN AMERICA 256
13.6 MIDDLE EAST & AFRICA 260
13.6.1 GCC COUNTRIES 265
13.6.1.1 Increasing healthcare modernization and rising investments in advanced medical technologies to drive market growth 265
13.6.2 REST OF MIDDLE EAST AND AFRICA 270
14 COMPETITIVE LANDSCAPE 275
14.1 INTRODUCTION 275
14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 275
14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ABLATION TECHNOLOGY MARKET 275
14.3 REVENUE ANALYSIS, 2021–2025 277
14.4 MARKET SHARE ANALYSIS, 2025 278
14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 280
14.5.1 STARS 280
14.5.2 EMERGING LEADERS 280
14.5.3 PERVASIVE PLAYERS 280
14.5.4 PARTICIPANTS 280
14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 282
14.5.5.1 Company footprint 282
14.5.5.2 Region footprint 283
14.5.5.3 Type footprint 284
14.5.5.4 Product footprint 285
14.5.5.5 Application footprint 286
14.5.5.6 End-user footprint 287

14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 288
14.6.1 PROGRESSIVE COMPANIES 288
14.6.2 DYNAMIC COMPANIES 288
14.6.3 STARTING BLOCKS 288
14.6.4 RESPONSIVE COMPANIES 288
14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 289
14.7 COMPANY VALUATION AND FINANCIAL METRICS 290
14.7.1 FINANCIAL METRICS 290
14.7.2 COMPANY VALUATION 291
14.7.3 BRAND COMPARISON 292
14.8 COMPETITIVE SCENARIO 293
14.8.1 PRODUCT APPROVALS 293
14.8.2 DEALS 294
14.8.3 OTHER DEVELOPMENTS 294
15 COMPANY PROFILES 295
15.1 KEY PLAYERS 295
15.1.1 JOHNSON & JOHNSON 295
15.1.1.1 Business overview 295
15.1.1.2 Products offered 296
15.1.1.3 Recent developments 297
15.1.1.3.1 Product approvals 297
15.1.1.3.2 Deals 298
15.1.1.3.3 Other developments 298
15.1.1.4 MnM view 298
15.1.1.4.1 Key strengths 298
15.1.1.4.2 Strategic choices 299
15.1.1.4.3 Weaknesses and competitive threats 299
15.1.2 MEDTRONIC 300
15.1.2.1 Business overview 300
15.1.2.2 Products offered 301
15.1.2.3 Recent developments 304
15.1.2.3.1 Product approvals 304
15.1.2.3.2 Deals 305
15.1.2.4 MnM view 305
15.1.2.4.1 Key strengths 305
15.1.2.4.2 Strategic choices 306
15.1.2.4.3 Weaknesses and competitive threats 306
15.1.3 BOSTON SCIENTIFIC CORPORATION 307
15.1.3.1 Business overview 307
15.1.3.2 Products offered 308
15.1.3.3 Recent developments 310
15.1.3.3.1 Product approvals 310
15.1.3.3.2 Deals 311
15.1.3.4 MnM view 312
15.1.3.4.1 Key strengths 312
15.1.3.4.2 Strategic choices made 312
15.1.3.4.3 Weaknesses and competitive threats 312
15.1.4 ABBOTT LABORATORIES 313
15.1.4.1 Business overview 313
15.1.4.2 Products offered 314
15.1.4.3 Recent developments 315
15.1.4.3.1 Product approvals 315
15.1.4.3.2 Deals 315
15.1.4.4 MnM view 316
15.1.4.4.1 Key strengths 316
15.1.4.4.2 Strategic choices made 316
15.1.4.4.3 Weaknesses and competitive threats 316
15.1.5 ATRICURE, INC. 317
15.1.5.1 Business overview 317
15.1.5.2 Products offered 318
15.1.5.3 Recent developments 319
15.1.5.3.1 Product launches and approvals 319
15.1.5.4 MnM view 320
15.1.5.4.1 Key strengths 320
15.1.5.4.2 Strategic choices made 320
15.1.5.4.3 Weaknesses and competitive threats 320
15.1.6 ANGIODYNAMICS 321
15.1.6.1 Business overview 321
15.1.6.2 Products offered 322
15.1.6.3 Recent developments 323
15.1.6.3.1 Product approvals 323
15.1.6.3.2 Deals 323
15.1.7 CONMED CORPORATION 324
15.1.7.1 Business overview 324
15.1.7.2 Products offered 325
15.1.8 OLYMPUS CORPORATION 326
15.1.8.1 Products offered 327
15.1.8.2 Recent developments 328
15.1.8.2.1 Product launches 328
15.1.8.2.2 Deals 328
15.1.9 VARIAN MEDICAL SYSTEMS, INC. 329
15.1.9.1 Business overview 329
15.1.9.2 Products offered 330
15.1.9.3 Recent developments 331
15.1.9.3.1 Product launches & approvals 331
15.1.9.3.2 Deals 331
15.1.10 SMITH+NEPHEW 333
15.1.10.1 Business overview 333
15.1.10.2 Product offered 334
15.1.10.3 Recent developments 335
15.1.10.3.1 Expansions 335
15.1.11 STRYKER 336
15.1.11.1 Business overview 336
15.1.11.2 Products offered 337
15.1.11.3 Recent developments 337
15.1.11.3.1 Product approvals 337
15.1.11.3.2 Expansions 338
15.1.12 MICROPORT SCIENTIFIC CORPORATION 339
15.1.12.1 Business overview 339
15.1.12.2 Products offered 340
15.1.12.3 Recent developments 341
15.1.12.3.1 Product approvals 341
15.1.13 CYNOSURE LUTRONIC 342
15.1.13.1 Business overview 342
15.1.13.2 Products offered 342
15.1.13.3 Recent developments 343
15.1.13.3.1 Deals 343
15.1.14 BIOTRONIK SE & CO. KG 344
15.1.14.1 Business overview 344
15.1.14.2 Products offered 344
15.1.14.3 Recent developments 345
15.1.14.3.1 Deals 345
15.1.15 MERIT MEDICAL SYSTEMS 346
15.1.15.1 Business overview 346
15.1.15.2 Products offered 347
15.1.15.3 Recent developments 348
15.1.15.3.1 Deals 348
15.1.16 ARTHREX, INC. 349
15.1.16.1 Business overview 349
15.1.16.2 Products offered 349
15.2 OTHER PLAYERS 350
15.2.1 HOLOGIC, INC. 350
15.2.2 ICECURE MEDICAL 351
15.2.3 MINIMAX MEDICAL HOLDING GROUP 352
15.2.4 CARDIOFOCUS 353
15.2.5 EMBLATION LTD. 354
15.2.6 MERMAID MEDICAL 355
15.2.7 MONTERIS 355
15.2.8 SONABLATE CORP. 356
15.2.9 ECO MEDICAL 357
15.2.10 SURGNOVA 358
16 RESEARCH METHODOLOGY 359
16.1 RESEARCH DATA 359
16.1.1 SECONDARY DATA 360
16.1.1.1 Key secondary sources 360
16.1.1.2 Objectives of secondary research 360
16.1.1.3 Key data from secondary sources 361
16.1.2 PRIMARY DATA 361
16.1.2.1 Key data from primary sources 362
16.1.2.2 Key industry insights 363
16.2 MARKET SIZE ESTIMATION 363
16.2.1 BOTTOM-UP APPROACH 363
16.2.2 TOP-DOWN APPROACH 364
16.2.3 BASE NUMBER ESTIMATION 364
16.3 MARKET FORECAST APPROACH 366
16.4 MARKET BREAKDOWN AND DATA TRIANGULATION 368
16.5 ASSUMPTIONS 369
16.6 GROWTH RATE ASSUMPTIONS 369
16.7 FACTOR ANALYSIS 370
16.8 RISK ASSESSMENT 370
16.9 METHODOLOGY-RELATED LIMITATIONS 371
17 APPENDIX 372
17.1 DISCUSSION GUIDE 372
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 377
17.3 CUSTOMIZATION OPTIONS 379
17.4 RELATED REPORTS 379
17.5 AUTHOR DETAILS 380

LIST OF TABLES

TABLE 1 ABLATION TECHNOLOGY MARKET: INCLUSIONS AND EXCLUSIONS 35
TABLE 2 ESTIMATED GERIATRIC POPULATION, BY REGION, 2023 VS. 2050 (IN MILLION) 51
TABLE 3 ALTERNATIVE THERAPIES/PROCEDURES FOR ABLATION 53
TABLE 4 ABLATION TECHNOLOGY MARKET: CURRENT UNMET NEEDS 58
TABLE 5 ABLATION TECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS 64
TABLE 6 GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021-2030 66
TABLE 7 AVERAGE SELLING PRICE TREND OF ABLATION TECHNOLOGIES FOR TOP THREE APPLICATIONS, BY KEY PLAYER, 2025 (USD MILLION) 72
TABLE 8 AVERAGE PRICING TREND OF ABLATION TECHNOLOGIES, BY REGION,
2023–2025 (USD MILLION) 72
TABLE 9 IMPORT DATA FOR ABLATION PRODUCTS (HS CODE 9018), BY COUNTRY,
2021–2025 (USD THOUSAND) 73
TABLE 10 EXPORT DATA FOR ABLATION PRODUCTS (HS CODE 9018), BY COUNTRY,
2021–2025 (USD THOUSAND) 74
TABLE 11 ABLATION TECHNOLOGY MARKET: DETAILED LIST OF
KEY CONFERENCES AND EVENTS (2026–2027) 74
TABLE 12 US ADJUSTED RECIPROCAL TARIFF RATES 79
TABLE 13 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR ABLATION TECHNOLOGY 79
TABLE 14 THERMAL ABLATION TECHNOLOGY: KEY BRAND MAPPING 83
TABLE 15 NON-THERMAL ABLATION TECHNOLOGY: KEY BRAND MAPPING 84
TABLE 16 ABLATION TECHNOLOGY MARKET: CASE STUDIES RELATED
TO AI IMPLEMENTATION 93
TABLE 17 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS 94
TABLE 18 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 97
TABLE 19 US FDA: MEDICAL DEVICE CLASSIFICATION 98
TABLE 20 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 98
TABLE 21 US: CLASSIFICATION OF ABLATION DEVICES 99
TABLE 22 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 100
TABLE 23 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA) 104
TABLE 24 CHINA: CLASSIFICATION OF MEDICAL DEVICES 105
TABLE 25 GLOBAL STANDARDS IN ABLATION TECHNOLOGY MARKET 107
TABLE 26 CERTIFICATIONS, LABELING, ECO-STANDARDS IN ABLATION TECHNOLOGY MARKET 108
TABLE 27 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS 110
TABLE 28 KEY BUYING CRITERIA FOR END USERS 111
TABLE 29 ABLATION TECHNOLOGY MARKET: UNMET NEEDS/END-USER EXPECTATIONS 112
TABLE 30 ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 115
TABLE 31 RADIOFREQUENCY ABLATION TECHNOLOGY MARKET, BY REGION,
2024–2031 (USD MILLION) 116
TABLE 32 LASER/LIGHT ABLATION TECHNOLOGY MARKET, BY REGION,
2024–2031 (USD MILLION) 117
TABLE 33 ULTRASOUND ABLATION TECHNOLOGY MARKET, BY REGION,
2024–2031 (USD MILLION) 118
TABLE 34 CRYOABLATION TECHNOLOGY MARKET, BY REGION, 2024–2031 (USD MILLION) 120
TABLE 35 MICROWAVE ABLATION TECHNOLOGY MARKET, BY REGION,
2024–2031 (USD MILLION) 121
TABLE 36 PULSED FIELD ABLATION TECHNOLOGY MARKET, BY REGION,
2024–2031 (USD MILLION) 122
TABLE 37 HYDROTHERMAL/HYDROMECHANICAL ABLATION TECHNOLOGY MARKET,
BY REGION, 2024–2031 (USD MILLION) 123
TABLE 38 OTHER ABLATION TECHNOLOGIES MARKET, BY REGION,
2024–2031 (USD MILLION) 124
TABLE 39 ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 126
TABLE 40 ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 126
TABLE 41 RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 127
TABLE 42 RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 127
TABLE 43 RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY REGION,
2024–2031 (MILLION UNITS) 128
TABLE 44 TEMPERATURE-CONTROLLED RF ABLATION SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 129
TABLE 45 IRRIGATED RF ABLATION SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 130
TABLE 46 MULTI-ELECTRODE RF ABLATION SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 131
TABLE 47 BIPOLAR RF ABLATION SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 132
TABLE 48 LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 132
TABLE 49 LASER/LIGHT ABLATION SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 133
TABLE 50 LASER/LIGHT ABLATION SYSTEMS MARKET, BY REGION,
2024–2031 (MILLION UNITS) 133
TABLE 51 EXCIMER LASER ABLATION SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 134
TABLE 52 CO2 LASER ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 135
TABLE 53 DIODE LASER ABLATION SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 136
TABLE 54 OTHER LASER/LIGHT ABLATION SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 137
TABLE 55 ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 137
TABLE 56 ULTRASOUND ABLATION SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 138
TABLE 57 ULTRASOUND ABLATION SYSTEMS MARKET, BY REGION,
2024–2031 (MILLION UNITS) 138
TABLE 58 HIFU ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 139
TABLE 59 MRGFUS ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 140
TABLE 60 CRYOABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 141
TABLE 61 CRYOABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (MILLION UNITS) 141
TABLE 62 PULSED FIELD ABLATION SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 142
TABLE 63 PULSED FIELD ABLATION SYSTEMS MARKET, BY REGION,
2024–2031 (MILLION UNITS) 142
TABLE 64 MICROWAVE ABLATION SYSTEMS MARKET, BY REGION,
2024–2031 (USD MILLION) 143
TABLE 65 MICROWAVE ABLATION SYSTEMS MARKET, BY REGION,
2024–2031 (MILLION UNITS) 144
TABLE 66 HYDROTHERMAL/HYDROMECHANICAL ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 144
TABLE 67 HYDROTHERMAL/HYDROMECHANICAL ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (MILLION UNITS) 145
TABLE 68 OTHER ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 146
TABLE 69 OTHER ABLATION SYSTEMS MARKET, BY REGION, 2024–2031 (MILLION UNITS) 146
TABLE 70 ABLATION CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 147
TABLE 71 ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 149
TABLE 72 ABLATION TECHNOLOGY MARKET FOR CVD TREATMENT, BY REGION,
2024–2031 (USD MILLION) 150
TABLE 73 ABLATION TECHNOLOGY MARKET FOR CANCER TREATMENT, BY REGION,
2024–2031 (USD MILLION) 152
TABLE 74 ABLATION TECHNOLOGY MARKET FOR ORTHOPEDIC TREATMENT,
BY REGION, 2024–2031 (USD MILLION) 153
TABLE 75 ABLATION TECHNOLOGY MARKET FOR COSMETIC/AESTHETIC SURGERY,
BY REGION, 2024–2031 (USD MILLION) 154
TABLE 76 ABLATION TECHNOLOGY MARKET FOR UROLOGICAL TREATMENT,
BY REGION, 2024–2031 (USD MILLION) 155
TABLE 77 ABLATION TECHNOLOGY MARKET FOR GYNECOLOGICAL TREATMENT,
BY REGION, 2024–2031 (USD MILLION) 156
TABLE 78 ABLATION TECHNOLOGY MARKET FOR PAIN MANAGEMENT, BY REGION,
2024–2031 (USD MILLION) 157
TABLE 79 ABLATION TECHNOLOGY MARKET FOR OPHTHALMOLOGICAL TREATMENT,
BY REGION, 2024–2031 (USD MILLION) 158
TABLE 80 ABLATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY REGION,
2024–2031 (USD MILLION) 158
TABLE 81 ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 160
TABLE 82 ABLATION TECHNOLOGY MARKET FOR HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS, BY REGION, 2024–2031 (USD MILLION) 161
TABLE 83 ABLATION TECHNOLOGY MARKET FOR AMBULATORY SURGERY CENTERS,
BY REGION, 2024–2031 (USD MILLION) 162
TABLE 84 ABLATION TECHNOLOGY MARKET FOR MEDICAL SPAS AND AESTHETIC & DERMATOLOGY CLINICS, BY REGION, 2024–2031 (USD MILLION) 163
TABLE 85 ABLATION TECHNOLOGY MARKET FOR OTHER END USERS, BY REGION,
2024–2031 (USD MILLION) 163
TABLE 86 ABLATION TECHNOLOGY MARKET, BY REGION, 2024–2031 (USD MILLION) 165
TABLE 87 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 166
TABLE 88 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY TYPE,
2024–2031 (USD MILLION) 167
TABLE 89 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 167
TABLE 90 NORTH AMERICA: ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 168
TABLE 91 NORTH AMERICA: RADIOFREQUENCY ABLATION SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 168
TABLE 92 NORTH AMERICA: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 169
TABLE 93 NORTH AMERICA: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 169
TABLE 94 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 170
TABLE 95 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY END USER,
2024–2031 (USD MILLION) 170
TABLE 96 US: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 171
TABLE 97 US: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 172
TABLE 98 US: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 172
TABLE 99 US: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 173
TABLE 100 US: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 173
TABLE 101 US: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 174
TABLE 102 US: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 174
TABLE 103 US: ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 175
TABLE 104 CANADA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 176
TABLE 105 CANADA: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 176
TABLE 106 CANADA: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 177
TABLE 107 CANADA: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 177
TABLE 108 CANADA: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 178
TABLE 109 CANADA: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 178
TABLE 110 CANADA: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 179
TABLE 111 CANADA: ABLATION TECHNOLOGY MARKET, BY END USER,
2024–2031 (USD MILLION) 179
TABLE 112 EUROPE: ABLATION TECHNOLOGY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 180
TABLE 113 EUROPE: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 181
TABLE 114 EUROPE: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 181
TABLE 115 EUROPE: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 182
TABLE 116 EUROPE: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 182
TABLE 117 EUROPE: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 183
TABLE 118 EUROPE: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 183
TABLE 119 EUROPE: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 184
TABLE 120 EUROPE: ABLATION TECHNOLOGY MARKET, BY END USER,
2024–2031 (USD MILLION) 184
TABLE 121 GERMANY: ABLATION TECHNOLOGY MARKET, BY TYPE,
2024–2031 (USD MILLION) 185
TABLE 122 GERMANY: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 186
TABLE 123 GERMANY: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 186
TABLE 124 GERMANY: RADIOFREQUENCY ABLATION SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 187
TABLE 125 GERMANY: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 187
TABLE 126 GERMANY: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 188
TABLE 127 GERMANY: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 188
TABLE 128 GERMANY: ABLATION TECHNOLOGY MARKET, BY END USER,
2024–2031 (USD MILLION) 189
TABLE 129 FRANCE: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 190
TABLE 130 FRANCE: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 190
TABLE 131 FRANCE: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 191
TABLE 132 FRANCE: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 191
TABLE 133 FRANCE: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 192
TABLE 134 FRANCE: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 192
TABLE 135 FRANCE: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 193
TABLE 136 FRANCE: ABLATION TECHNOLOGY MARKET, BY END USER,
2024–2031 (USD MILLION) 193
TABLE 137 UK: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 194
TABLE 138 UK: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 195
TABLE 139 UK: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 195
TABLE 140 UK: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 196
TABLE 141 UK: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 196
TABLE 142 UK: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 197
TABLE 143 UK: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 197
TABLE 144 UK: ABLATION TECHNOLOGY MARKET, BY END USER, 2024–2031 (USD MILLION) 198
TABLE 145 ITALY: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 199
TABLE 146 ITALY: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 199
TABLE 147 ITALY: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 200
TABLE 148 ITALY: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 200
TABLE 149 ITALY: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 201
TABLE 150 ITALY: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 201
TABLE 151 ITALY: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 202
TABLE 152 ITALY: ABLATION TECHNOLOGY MARKET, BY END USER,
2024–2031 (USD MILLION) 202
TABLE 153 SPAIN: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 203
TABLE 154 SPAIN: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 203
TABLE 155 SPAIN: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 204
TABLE 156 SPAIN: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 204
TABLE 157 SPAIN: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 205
TABLE 158 SPAIN: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 205
TABLE 159 SPAIN: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 206
TABLE 160 SPAIN: ABLATION TECHNOLOGY MARKET, BY END USER,
2024–2031 (USD MILLION) 206
TABLE 161 REST OF EUROPE: ABLATION TECHNOLOGY MARKET, BY TYPE,
2024–2031 (USD MILLION) 207
TABLE 162 REST OF EUROPE: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 208
TABLE 163 REST OF EUROPE: ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 208
TABLE 164 REST OF EUROPE: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 209
TABLE 165 REST OF EUROPE: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 209
TABLE 166 REST OF EUROPE: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 210
TABLE 167 REST OF EUROPE: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 210
TABLE 168 REST OF EUROPE: ABLATION TECHNOLOGY MARKET, BY END USER,
2024–2031 (USD MILLION) 211
TABLE 169 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 212
TABLE 170 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY TYPE,
2024–2031 (USD MILLION) 213
TABLE 171 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 213
TABLE 172 ASIA PACIFIC: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 214
TABLE 173 ASIA PACIFIC: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 214
TABLE 174 ASIA PACIFIC: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 215
TABLE 175 ASIA PACIFIC: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 215
TABLE 176 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 216
TABLE 177 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY END USER,
2024–2031 (USD MILLION) 216
TABLE 178 JAPAN: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 217
TABLE 179 JAPAN: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 218
TABLE 180 JAPAN: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 218
TABLE 181 JAPAN: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 219
TABLE 182 JAPAN: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 219
TABLE 183 JAPAN: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 220
TABLE 184 JAPAN: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 220
TABLE 185 JAPAN: ABLATION TECHNOLOGY MARKET, BY END USER,
2024–2031 (USD MILLION) 221
TABLE 186 CHINA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 222
TABLE 187 CHINA: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 222
TABLE 188 CHINA: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 223
TABLE 189 CHINA: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 223
TABLE 190 CHINA: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 224
TABLE 191 CHINA: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 224
TABLE 192 CHINA: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 225
TABLE 193 CHINA: ABLATION TECHNOLOGY MARKET, BY END USER,
2024–2031 (USD MILLION) 225
TABLE 194 INDIA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 226
TABLE 195 INDIA: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 227
TABLE 196 INDIA: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 227
TABLE 197 INDIA: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 228
TABLE 198 INDIA: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 228
TABLE 199 INDIA: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 229
TABLE 200 INDIA: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 229
TABLE 201 INDIA: ABLATION TECHNOLOGY MARKET, BY END USER,
2024–2031 (USD MILLION) 230
TABLE 202 AUSTRALIA: ABLATION TECHNOLOGY MARKET, BY TYPE,
2024–2031 (USD MILLION) 231
TABLE 203 AUSTRALIA: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 231
TABLE 204 AUSTRALIA: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 232
TABLE 205 AUSTRALIA: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 232
TABLE 206 AUSTRALIA: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 233
TABLE 207 AUSTRALIA: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 233
TABLE 208 AUSTRALIA: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 234
TABLE 209 AUSTRALIA: ABLATION TECHNOLOGY MARKET, BY END USER,
2024–2031 (USD MILLION) 234
TABLE 210 SOUTH KOREA: ABLATION TECHNOLOGY MARKET, BY TYPE,
2024–2031 (USD MILLION) 235
TABLE 211 SOUTH KOREA: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 235
TABLE 212 SOUTH KOREA: ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 236
TABLE 213 SOUTH KOREA: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 236
TABLE 214 SOUTH KOREA: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 237
TABLE 215 SOUTH KOREA: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 237
TABLE 216 SOUTH KOREA: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 238
TABLE 217 SOUTH KOREA: ABLATION TECHNOLOGY MARKET, BY END USER,
2024–2031 (USD MILLION) 238
TABLE 218 REST OF ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY TYPE,
2024–2031 (USD MILLION) 239
TABLE 219 REST OF ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 239
TABLE 220 REST OF ASIA PACIFIC: ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 240
TABLE 221 REST OF ASIA PACIFIC: RADIOFREQUENCY ABLATION SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 240
TABLE 222 REST OF ASIA PACIFIC: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 241
TABLE 223 REST OF ASIA PACIFIC: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 241
TABLE 224 REST OF ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 242
TABLE 225 REST OF ASIA PACIFIC: ABLATION TECHNOLOGY MARKET, BY END USER,
2024–2031 (USD MILLION) 242
TABLE 226 LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 243
TABLE 227 LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY TYPE,
2024–2031 (USD MILLION) 243
TABLE 228 LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 244
TABLE 229 LATIN AMERICA: ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 244
TABLE 230 LATIN AMERICA: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 245
TABLE 231 LATIN AMERICA: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 245
TABLE 232 LATIN AMERICA: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 246
TABLE 233 LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 246
TABLE 234 LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY END USER,
2024–2031 (USD MILLION) 247
TABLE 235 BRAZIL: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 248
TABLE 236 BRAZIL: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 248
TABLE 237 BRAZIL: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 249
TABLE 238 BRAZIL: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 249
TABLE 239 BRAZIL: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 250
TABLE 240 BRAZIL: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 250
TABLE 241 BRAZIL: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 251
TABLE 242 BRAZIL: ABLATION TECHNOLOGY MARKET, BY END USER,
2024–2031 (USD MILLION) 251
TABLE 243 MEXICO: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 252
TABLE 244 MEXICO: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 253
TABLE 245 MEXICO: ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 253
TABLE 246 MEXICO: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 254
TABLE 247 MEXICO: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 254
TABLE 248 MEXICO: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 255
TABLE 249 MEXICO: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 255
TABLE 250 MEXICO: ABLATION TECHNOLOGY MARKET, BY END USER,
2024–2031 (USD MILLION) 256
TABLE 251 REST OF LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY TYPE,
2024–2031 (USD MILLION) 256
TABLE 252 REST OF LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 257
TABLE 253 REST OF LATIN AMERICA: ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 257
TABLE 254 REST OF LATIN AMERICA: RADIOFREQUENCY ABLATION SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 258
TABLE 255 REST OF LATIN AMERICA: LASER/LIGHT ABLATION SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 258
TABLE 256 REST OF LATIN AMERICA: ULTRASOUND ABLATION SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 259
TABLE 257 REST OF LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 259
TABLE 258 REST OF LATIN AMERICA: ABLATION TECHNOLOGY MARKET, BY END USER,
2024–2031 (USD MILLION) 260
TABLE 259 MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY REGION,
2024–2031 (USD MILLION) 261
TABLE 260 MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY TYPE,
2024–2031 (USD MILLION) 261
TABLE 261 MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 262
TABLE 262 MIDDLE EAST & AFRICA: ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 262
TABLE 263 MIDDLE EAST & AFRICA: RADIOFREQUENCY ABLATION SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 263
TABLE 264 MIDDLE EAST & AFRICA: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 263
TABLE 265 MIDDLE EAST & AFRICA: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 264
TABLE 266 MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 264
TABLE 267 MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY END USER,
2024–2031 (USD MILLION) 265
TABLE 268 GCC COUNTRIES: ABLATION TECHNOLOGY MARKET, BY TYPE,
2024–2031 (USD MILLION) 266
TABLE 269 GCC COUNTRIES: ABLATION TECHNOLOGY MARKET, BY PRODUCT,
2024–2031 (USD MILLION) 266
TABLE 270 GCC COUNTRIES: ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 267
TABLE 271 GCC COUNTRIES: RADIOFREQUENCY ABLATION SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 267
TABLE 272 GCC COUNTRIES: LASER/LIGHT ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 268
TABLE 273 GCC COUNTRIES: ULTRASOUND ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 268
TABLE 274 GCC COUNTRIES: ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 269
TABLE 275 GCC COUNTRIES: ABLATION TECHNOLOGY MARKET, BY END USER,
2024–2031 (USD MILLION) 269
TABLE 276 REST OF MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2024–2031 (USD MILLION) 270
TABLE 277 REST OF MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 271
TABLE 278 REST OF MIDDLE EAST & AFRICA: ABLATION SYSTEMS MARKET, BY TYPE,
2024–2031 (USD MILLION) 271
TABLE 279 REST OF MIDDLE EAST & AFRICA: RADIOFREQUENCY ABLATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 272
TABLE 280 REST OF MIDDLE EAST & AFRICA: LASER/LIGHT ABLATION SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 272
TABLE 281 REST OF MIDDLE EAST & AFRICA: ULTRASOUND ABLATION SYSTEMS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 273
TABLE 282 REST OF MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET,
BY APPLICATION, 2024–2031 (USD MILLION) 273
TABLE 283 REST OF MIDDLE EAST & AFRICA: ABLATION TECHNOLOGY MARKET,
BY END USER, 2024–2031 (USD MILLION) 274
TABLE 284 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN ABLATION TECHNOLOGY MARKET 275
TABLE 285 ABLATION TECHNOLOGY MARKET: DEGREE OF COMPETITION 278
TABLE 286 ABLATION TECHNOLOGY MARKET: REGION FOOTPRINT 283
TABLE 287 ABLATION TECHNOLOGY MARKET: TECHNOLOGY FOOTPRINT 284
TABLE 288 ABLATION TECHNOLOGY MARKET: PRODUCT FOOTPRINT 285
TABLE 289 ABLATION TECHNOLOGY MARKET: APPLICATION FOOTPRINT 286
TABLE 290 ABLATION TECHNOLOGY MARKET: END-USER FOOTPRINT 287
TABLE 291 ABLATION TECHNOLOGY MARKET: DETAILED LIST OF KEY STARTUPS/SMES 289
TABLE 292 ABLATION TECHNOLOGY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 290
TABLE 293 ABLATION TECHNOLOGY MARKET: PRODUCT APPROVALS,
JANUARY 2021–MAY 2026 293
TABLE 294 ABLATION TECHNOLOGY MARKET: DEALS, JANUARY 2021–MAY 2026 294
TABLE 295 ABLATION TECHNOLOGY MARKET: OTHER DEVELOPMENTS,
JANUARY 2021–MAY 2026 294
TABLE 296 JOHNSON & JOHNSON: COMPANY OVERVIEW 295
TABLE 297 JOHNSON & JOHNSON: PRODUCTS OFFERED 296
TABLE 298 JOHNSON & JOHNSON: PRODUCT APPROVALS, JANUARY 2021–MAY 2026 297
TABLE 299 JOHNSON & JOHNSON: DEALS, JANUARY 2021–MAY 2026 298
TABLE 300 JOHNSON & JOHNSON: OTHER DEVELOPMENTS, JANUARY 2021−MAY 2026 298
TABLE 301 MEDTRONIC: COMPANY OVERVIEW 300
TABLE 302 MEDTRONIC: PRODUCTS OFFERED 301
TABLE 303 MEDTRONIC: PRODUCT APPROVALS, JANUARY 2021–MAY 2026 304
TABLE 304 MEDTRONIC: DEALS, JANUARY 2021–MAY 2026 305
TABLE 305 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 307
TABLE 306 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 308
TABLE 307 BOSTON SCIENTIFIC CORPORATION: PRODUCT APPROVALS,
JANUARY 2021−MAY 2026 310
TABLE 308 BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021–MAY 2026 311
TABLE 309 ABBOTT LABORATORIES: COMPANY OVERVIEW 313
TABLE 310 ABBOTT LABORATORIES: PRODUCTS OFFERED 314
TABLE 311 ABBOTT LABORATORIES: PRODUCT APPROVALS, JANUARY 2021–MAY 2026 315
TABLE 312 ABBOTT LABORATORIES: DEALS, JANUARY 2021–MAY 2026 315
TABLE 313 ATRICURE, INC.: COMPANY OVERVIEW 317
TABLE 314 ATRICURE, INC.: PRODUCTS OFFERED 318
TABLE 315 ATRICURE, INC.: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2021−MAY 2026 319
TABLE 316 ANGIODYNAMICS: COMPANY OVERVIEW 321
TABLE 317 ANGIODYNAMICS: PRODUCTS OFFERED 322
TABLE 318 ANGIODYNAMICS: PRODUCT APPROVALS, JANUARY 2021–MAY 2026 323
TABLE 319 ANGIODYNAMICS: DEALS, JANUARY 2021–MAY 2026 323
TABLE 320 CONMED CORPORATION: COMPANY OVERVIEW 324
TABLE 321 CONMED CORPORATION: PRODUCTS OFFERED 325
TABLE 322 OLYMPUS CORPORATION: COMPANY OVERVIEW 326
TABLE 323 OLYMPUS CORPORATION: PRODUCTS OFFERED 327
TABLE 324 OLYMPUS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021- FEBRUARY 2025 328
TABLE 325 OLYMPUS CORPORATION: DEALS, JANUARY 2021- FEBRUARY 2025 328
TABLE 326 VARIAN MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW 329
TABLE 327 VARIAN MEDICAL SYSTEMS, INC.: PRODUCTS OFFERED 330
TABLE 328 VARIAN MEDICAL SYSTEMS, INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021−MAY 2026 331
TABLE 329 VARIAN MEDICAL SYSTEMS, INC.: DEALS, JANUARY 2021–MAY 2026 331
TABLE 330 SMITH+NEPHEW: COMPANY OVERVIEW 333
TABLE 331 SMITH+NEPHEW: PRODUCTS OFFERED 334
TABLE 332 SMITH+NEPHEW: EXPANSIONS, JANUARY 2021–MAY 2026 335
TABLE 333 STRYKER: COMPANY OVERVIEW 336
TABLE 334 STRYKER: PRODUCTS OFFERED 337
TABLE 335 STRYKER: PRODUCT APPROVALS, JANUARY 2021–MAY 2026 337
TABLE 336 STRYKER: EXPANSIONS, JANUARY 2021- FEBRUARY 2025 338
TABLE 337 MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW 339
TABLE 338 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED 340
TABLE 339 MICROPORT SCIENTIFIC CORPORATION: PRODUCT APPROVALS,
JANUARY 2021–MAY 2026 341
TABLE 340 CYNOSURE LUTRONIC: COMPANY OVERVIEW 342
TABLE 341 CYNOSURE LUTRONIC: PRODUCTS OFFERED 342
TABLE 342 CYNOSURE LUTRONIC: DEALS, JANUARY 2021- FEBRUARY 2025 343
TABLE 343 BIOTRONIK SE & CO. KG: COMPANY OVERVIEW 344
TABLE 344 BIOTRONIK SE & CO. KG: PRODUCTS OFFERED 344
TABLE 345 BIOTRONIK SE & CO. KG: DEALS, JANUARY 2021–MAY 2026 345
TABLE 346 MERIT MEDICAL SYSTEMS: COMPANY OVERVIEW 346
TABLE 347 MERIT MEDICAL SYSTEMS: PRODUCTS OFFERED 347
TABLE 348 MERIT MEDICAL SYSTEMS: DEALS, JANUARY 2021−MAY 2026 348
TABLE 349 ARTHREX, INC.: COMPANY OVERVIEW 349
TABLE 350 ARTHREX, INC.: PRODUCTS OFFERED 349
TABLE 351 HOLOGIC, INC.: COMPANY OVERVIEW 350
TABLE 352 ICECURE MEDICAL: COMPANY OVERVIEW 351
TABLE 353 MINIMAX MEDICAL HOLDING GROUP: COMPANY OVERVIEW 352
TABLE 354 CARDIOFOCUS: COMPANY OVERVIEW 353
TABLE 355 EMBLATION LTD.: COMPANY OVERVIEW 354
TABLE 356 MERMAID MEDICAL: COMPANY OVERVIEW 355
TABLE 357 MONTERIS: COMPANY OVERVIEW 355
TABLE 358 SONABLATE CORP.: COMPANY OVERVIEW 356
TABLE 359 ECO MEDICAL: COMPANY OVERVIEW 357
TABLE 360 SURGNOVA: COMPANY OVERVIEW 358
TABLE 361 ABLATION TECHNOLOGY MARKET: STUDY ASSUMPTIONS 369
TABLE 362 ABLATION TECHNOLOGY MARKET: RISK ASSESSMENT 370

LIST OF FIGURES

FIGURE 1 ABLATION TECHNOLOGY MARKET: YEARS CONSIDERED 35
FIGURE 2 KEY INSIGHTS & MARKET HIGHLIGHTS 38
FIGURE 3 ABLATION TECHNOLOGY MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION) 39
FIGURE 4 ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2026 VS. 2031 (USD MILLION) 39
FIGURE 5 ABLATION TECHNOLOGY MARKET, BY APPLICATION,
2026 VS. 2031 (USD MILLION) 40
FIGURE 6 ABLATION TECHNOLOGY MARKET, BY END USER, 2026 VS. 2031 (USD MILLION) 41
FIGURE 7 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN ABLATION
TECHNOLOGY MARKET 41
FIGURE 8 DISRUPTIVE TRENDS IMPACTING GROWTH OF ABLATION TECHNOLOGY MARKET 42
FIGURE 9 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN ABLATION TECHNOLOGY MARKET, 2026 43
FIGURE 10 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 44
FIGURE 11 INCREASING DEMAND FOR MINIMALLY INVASIVE PROCEDURES TO DRIVE MARKET 45
FIGURE 12 CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF ABLATION
TECHNOLOGY MARKET IN 2025 46
FIGURE 13 INDIA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 47
FIGURE 14 NORTH AMERICA TO CONTINUE TO DOMINATE MARKET
DURING FORECAST PERIOD 48
FIGURE 15 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES 48
FIGURE 16 ABLATION TECHNOLOGY MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 49
FIGURE 17 ABLATION TECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS 64
FIGURE 18 ABLATION TECHNOLOGY MARKET SUPPLY CHAIN ANALYSIS 69
FIGURE 19 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING THE MANUFACTURING PHASE 70
FIGURE 20 ABLATION TECHNOLOGY MARKET: ECOSYSTEM ANALYSIS 71
FIGURE 21 TRENDS/DISRUPTIONS INFLUENCING CUSTOMERS’ BUSINESSES IN ABLATION 75
FIGURE 22 INVESTMENT/VENTURE CAPITAL SCENARIO IN ABLATION
TECHNOLOGY MARKET, 2020–2023 76
FIGURE 23 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR
ABLATION TECHNOLOGY MARKET (JANUARY 2016–APRIL 2026) 88
FIGURE 24 TOP PATENT APPLICANT COUNTRIES FOR ABLATION TECHNOLOGY (JANUARY 2016–APRIL 2026) 89
FIGURE 25 PREMARKET NOTIFICATION: 510(K) APPROVAL FOR MEDICAL DEVICES 99
FIGURE 26 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES 100
FIGURE 27 EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES 102
FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ABLATION TECHNOLOGY PRODUCTS 109
FIGURE 29 KEY BUYING CRITERIA FOR END USERS 110
FIGURE 30 NORTH AMERICA: ABLATION TECHNOLOGY MARKET SNAPSHOT 166
FIGURE 31 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET SNAPSHOT 212
FIGURE 32 REVENUE ANALYSIS OF KEY PLAYERS IN ABLATION TECHNOLOGY MARKET (2021−2025) 277
FIGURE 33 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ABLATION
TECHNOLOGY MARKET (2025) 278
FIGURE 34 ABLATION TECHNOLOGY MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2025 281
FIGURE 35 ABLATION TECHNOLOGY MARKET: COMPANY FOOTPRINT 282
FIGURE 36 ABLATION TECHNOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 289
FIGURE 37 EV/EBITDA OF KEY VENDORS 290
FIGURE 38 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR
STOCK BETA OF KEY VENDOR 291
FIGURE 39 ABLATION TECHNOLOGY MARKET: BRAND COMPARATIVE ANALYSIS 292
FIGURE 40 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2025) 296
FIGURE 41 MEDTRONIC: COMPANY SNAPSHOT (2025) 301
FIGURE 42 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2025) 308
FIGURE 43 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2025) 314
FIGURE 44 ATRICURE, INC.: COMPANY SNAPSHOT (2025) 318
FIGURE 45 ANGIODYNAMICS: COMPANY SNAPSHOT (2025) 322
FIGURE 46 CONMED CORPORATION: COMPANY SNAPSHOT (2025) 325
FIGURE 47 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2025) 327
FIGURE 48 VARIAN MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2025) 330
FIGURE 49 SMITH+NEPHEW: COMPANY SNAPSHOT (2025) 334
FIGURE 50 STRYKER: COMPANY SNAPSHOT (2024) 336
FIGURE 51 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2025) 340
FIGURE 52 MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT (2022) 347
FIGURE 53 ABLATION TECHNOLOGY MARKET: RESEARCH DESIGN 359
FIGURE 54 PRIMARY SOURCES 362
FIGURE 55 BOTTOM-UP APPROACH 364
FIGURE 56 TOP-DOWN APPROACH 364
FIGURE 57 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 365
FIGURE 58 REVENUE SHARE ANALYSIS ILLUSTRATION: JOHNSON &JOHNSON 365
FIGURE 59 SUPPLY-SIDE MARKET ESTIMATION: ABLATION TECHNOLOGY MARKET (2025) 366
FIGURE 60 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 367
FIGURE 61 DATA TRIANGULATION METHODOLOGY 368

---

---